GOVX: GeoVax Labs Sotuvga nisbatan narx
GeoVax Labs, Inc. (GOVX) klinik sinovlarni tashqi CRO hamkorlariga topshirish orqali xarajatlarni optimallashtirmoqda. GURU.Markets terminali grafigidagi sotuvlarga nisbatan narx koeffitsiyenti joriy dinamikani aks ettiradi, bunda 4.60 belgisi biznesning barqarorlik darajasini ko'rsatadi. Kompaniyaning istiqbollari onkologiya uchun uning shaxsiy MVA platformasiga asoslangan, barqarorlik esa AQSh laboratoriyalarida immunoterapiyani rivojlantirishga berilgan davlat yordami bilan ta'minlanadi.
GeoVax Labs Inc (GOVX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati GeoVax Labs, Inc.|GOVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati GeoVax Corp|GOVX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar GeoVax Labs Inc|GOVX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi GeoVax|Oraliq qoplash koeffitsiyenti geovax.com
- foyda va bozor multiplikatorlari tafsilotlari:
GOVX - Kompaniyaning sof foydasi|Kutilayotgan foyda GeoVax Labs, Inc.|GOVX - P/E multiplikatori|Forvard P/E multiplikatori GeoVax Labs|GOVX - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati GeoVax Labs Inc|GOVX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda GeoVax|GOVX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi geovax.com|GOVX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi GeoVax Labs, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:GOVX geovax.com
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga nisbatan belgilaydi, bu esa aktivning haddan tashqari qimmat baholanganligini baholash imkonini beradi. Investorlar sotuvlar to'xtab qolishi xatarlarini hisobga olgan holda, kirish nuqtalarini aniqlash uchun ushbu metrikadan foydalanadilar. GeoVax Labs, Inc. (GOVX) uchun narxning sotuvlarga nisbati koeffitsiyentini tahlil qilish juda muhimdir, chunki doimiy R&D xarajatlari ishlab chiqarishni autsorsing orqali kengaytirishda foydaning keskin o'sishi uchun imkoniyat yaratadi.
GeoVax Labs, Inc. kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Narx/daromad multiplikatori Protagonist Corp (PTGX)|IMVT: P/S multiplikatori|Sotuvga nisbatan narx kiniksa.com (KNSA)|Narxning daromadga nisbati Grifols|Sotuvga nisbatan narx Adaptive Biotech ADPT|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|Narxning daromadga nisbati AUPH (Aurinia Corp)|P/S multiplikatori BCRX (BioCryst)|P/S multiplikatori veratx.com VERA|DNTH: Kapitalizatsiyaning daromadga nisbati|PHVS (Pharvaris NV) - Kapitalizatsiya va daromad nisbati|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|Tourmaline - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Precigen, Inc.|Narxning daromadga nisbati PHAR|P/S multiplikatori NKTR|P/S multiplikatori Upstream Bio, Inc. (UPB)|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Immunome Bio - Narxning daromadga nisbati|GOSS - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti kalvista.com KALV|SEPN (Septerna) - Kapitalizatsiyaning daromadga nisbati|Pieris Pharma - Bozor kapitallashuvining daromadga nisbati|SVRA (Savara Corp) - P/S multiplikatori|Rigel Corp (RIGL) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati AnaptysBio, Inc. (ANAB)|astriatx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ENGN (enGene)|RAPT - Kapitalizatsiyaning daromadga nisbati|JBIO: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Aclaris Therapeutics, Inc ACRS|KYTX: P/S multiplikatori|Narx/daromad multiplikatori tizianalifesciences.com TLSA|Narxning daromadga nisbati Cabaletta Bio|Sotuvga nisbatan narx Ventyx Biosciences Inc. VTYX|Kapitalizatsiyaning daromadga nisbati THTX (Theratechnologies Inc)|Narxning daromadga nisbati AVTX (Avalo Therapeutics Inc)|Eledon Pharmaceuticals - Kapitalizatsiyaning daromadga nisbati|AGEN: Kapitalizatsiya va daromad nisbati|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ZURA|ATYR: P/S multiplikatori|Adagene Inc. - Bozor kapitallashuvining daromadga nisbati|IMA (ImageneBio) - P/S multiplikatori|P/S multiplikatori Shattuck Therapeutics|Narxning daromadga nisbati Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Immunic IMUX|ATRA - Kapitalizatsiyaning daromadga nisbati|InflaRx GmbH - P/S multiplikatori|XFOR - P/S multiplikatori|ACET (adicetbio.com) - Kapitalizatsiyaning daromadga nisbati|Celularity - Bozor kapitallashuvining daromadga nisbati|INMB (INmune Bio Corp) - P/S multiplikatori|Barinthus Biotherapeutics Corp (BRNS) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Kezar Life Sciences (KZR)|Kapitalizatsiyaning daromadga nisbati sabbiotherapeutics.com SABS|Narxning daromadga nisbati Akari Therapeutics Plc AKTX|ENLV - Kapitalizatsiyaning daromadga nisbati|QTTB: Kapitalizatsiyaning daromadga nisbati|EDSA - P/S multiplikatori|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CARM|XTLB (XTL Biopharmaceuticals Ltd.) - P/S multiplikatori|Sotuvga nisbatan narx Bolt Bio BOLT|P/S multiplikatori HCWB|aptevotherapeutics.com (APVO) - Narx/daromad multiplikatori|P/S multiplikatori AIM (AIM ImmunoTech Inc.)|Aditxt Inc. (ADTX) - Sotuvga nisbatan narx|GRI - Narxning daromadga nisbati|Sotuvga nisbatan narx XORTX Therapeutics Inc|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|REVB (Revelation Biosciences Corp) - Narxning daromadga nisbati|INDP (Indaptus Therapeutics) - P/S multiplikatori|P/S multiplikatori scinai.com|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|affimed.com - Kapitalizatsiya va daromad nisbati|Allakos - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati HOOK|IGMS - Narxning daromadga nisbati|ITOS: Narxning daromadga nisbati|OCEA: P/S multiplikatori|TC BioPharm (Holdings) Plc (TCBP) - P/S multiplikatori|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
